Compare MNDY & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNDY | CNC |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 18.5B |
| IPO Year | 2021 | 2001 |
| Metric | MNDY | CNC |
|---|---|---|
| Price | $157.28 | $38.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 24 | 17 |
| Target Price | ★ $279.33 | $40.06 |
| AVG Volume (30 Days) | 1.7M | ★ 8.4M |
| Earning Date | 11-10-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 192.87 | N/A |
| EPS | ★ 1.23 | N/A |
| Revenue | $1,166,095,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | $28.81 | $32.54 |
| Revenue Next Year | $21.57 | $0.19 |
| P/E Ratio | $128.02 | ★ N/A |
| Revenue Growth | ★ 28.62 | 14.57 |
| 52 Week Low | $141.20 | $25.08 |
| 52 Week High | $342.64 | $66.81 |
| Indicator | MNDY | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 55.23 |
| Support Level | $147.00 | $37.41 |
| Resistance Level | $148.97 | $39.34 |
| Average True Range (ATR) | 6.84 | 1.38 |
| MACD | 1.90 | 0.07 |
| Stochastic Oscillator | 77.66 | 70.49 |
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.